Harada, T
Dana-Farber Cancer Institute
3 papers on CoChatORCID 0000-0002-3997-7471
Most cited papers
- Verified
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
Görgün, G., Samur, M. K., Cowens, K. B., Paula, S., Bianchi, G., Anderson, J. E., White, R. E., Singh, A., Ohguchi, H., Suzuki, R., et al. (2015) · Clinical Cancer Research
Multiple Myeloma Research and TreatmentsCancer Immunotherapy and Biomarkers
Cited by 309
- Verified
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma
Gullà, A., Hideshima, T., Bianchi, G., Fulciniti, M., Kemal Samur, M., Qi, J., Tai, Y.-T., Harada, T., Morelli, E., Amodio, N., et al. (2018) · Leukemia
Cancer-related gene regulationMultiple Myeloma Research and Treatments
Cited by 102
- Verified
HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications
Harada, T., Ohguchi, H., Grondin, Y., Kikuchi, S., Sagawa, M., Tai, Y.-T., Mazitschek, R., Hideshima, T., & Anderson, K. C. (2017) · Leukemia
Histone Deacetylase Inhibitors ResearchMultiple Myeloma Research and Treatments
Cited by 89
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free